InvestorsHub Logo
Followers 21
Posts 1210
Boards Moderated 0
Alias Born 05/06/2014

Re: doogdilinger post# 17796

Monday, 09/19/2016 3:16:59 PM

Monday, September 19, 2016 3:16:59 PM

Post# of 38634
Excellent Doog - thanxs.

My guess is that Oxtenda will take the same path as Rexista did.

Extensive Phase 1 studies going directly to a Phase 3 study consisting of Bio Equivalency data.

We've been claiming that Rexista did/does not need a Phase 3 study... when in fact it did... it simply took the form of BE tests... it relies on objective data rather than a subjective opinion where subjective opinions are known to vary extremely.